患有直肠阴道瘘的晚期癌症患者的早期腹腔镜结肠造口术:七名患者的结果。
Early Laparoscopic Colostomy in Advanced Cancer Patients with Rectovaginal Fistula: Results of Seven Patients.
发表日期:2024 Aug 21
作者:
Satoshi Akita, Kei Ishimaru, Mitsunori Sato, Katsuya Watanabe, Hiroki Sugishita, Yusuke Ogi, Jun Kuwabara, Kazufumi Tanigawa, Satoshi Kikuchi, Hironori Matsumoto, Motohira Yoshida, Shigehiro Koga, Taro Oshikiri
来源:
MEDICINE & SCIENCE IN SPORTS & EXERCISE
摘要:
直肠阴道瘘(RVF)是直肠和阴道之间的异常管道,在许多情况下需要手术干预。尽管根据患者病情的不同,裂谷热有多种不同的治疗方法,但目前尚无既定的裂谷热治疗指南。本研究旨在评价腹腔镜结肠造口术治疗晚期癌症患者RVF的效果以及该手术的安全性和有效性。在这项研究中,2015年至2018年期间,我校医院收治了7名患有RVF的女性晚期癌症患者,并成功进行了腹腔镜结肠造口术治疗。他们的数据是根据他们的医疗记录进行回顾性评估的。早期使用改道造口有助于及时恢复癌症治疗,并能够及早进行化疗或放疗。尽管阴道粪便渗漏影响了三名患者,但所有患者均康复了,在癌症治疗期间既没有经历疼痛,也没有感染。虽然结肠造口术给患者带来了身心上的负担,但它改善了裂谷热引起的感染和疼痛。我们的结论是,早期使用分流造口有两个作用:显着改善感染管理和促进癌症治疗的快速恢复。
A rectovaginal fistula (RVF) is an abnormal tract between the rectum and vagina, which requires surgical intervention in many cases. Although there are many different therapeutic approaches for RVF depending on the patient's' condition, there are no established guidelines for the care of RVF. This study aimed to evaluate the results of laparoscopic colostomy in advanced cancer patients with RVF, and the safety and efficacy of this surgery. In this study, seven female advanced cancer patients with RVF were hospitalized and successfully treated with laparoscopic colostomy from 2015 to 2018 at our university hospital. Their data were retrospectively evaluated from their medical records. The early use of diverting stomas facilitated timely resumption of cancer treatment and enabled early treatment with chemotherapy or radiotherapy. Although vaginal stool leakage affected three patients, all patients recovered, experiencing neither pain nor infection during their cancer treatment. While colostomy was physically and mentally taxing for the patients, it improved the infection and pain caused by the RVF. We conclude that the early use of diverting stomas had two effects: a significant improvement in infection management and facilitation of the rapid resumption of cancer treatment.